aTYR PHARMA INC | Business Contracts

Underwriting Agreement by and between aTyr Pharma, Inc. and RBC Capital Markets, LLC (Filed With SEC on February 9, 2023)

Lease, dated May 12, 2022, by and between the Registrant and San Diego Creekside, LLC (Filed With SEC on May 16, 2022)

aTyr Pharma, Inc. 2022 Inducement Plan (Filed With SEC on May 10, 2022)

aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended (Filed With SEC on April 29, 2022)

Collaboration and License Agreement by and between Registrant and Kyorin Pharmaceutical Co., Ltd. agreement, dated January 6, 2020 (Filed With SEC on February 3, 2020)

Forms of Grant Notice and Stock Option Agreement under aTyr Pharma, Inc. 2022 Inducement Plan (Filed With SEC on May 10, 2022)

aTyr Pharma, Inc. 2015 Employee Stock Purchase Plan, as amended (Filed With SEC on April 29, 2022)

Open Market Sale AgreementSM, dated April 22, 2022, by and between aTyr Pharma, Inc. and Jefferies LLC (Filed With SEC on April 22, 2022)

Common Stock Capital on DemandTM Sales Agreement, between the Registrant and JonesTrading Institutional Services LLC (Filed With SEC on March 15, 2022)

Purchase Agreement, dated September 15, 2021, by and among aTyr Pharma, Inc., Piper Sandler & Co. and RBC Capital Markets, LLC (Filed With SEC on September 16, 2021)

ATYR PHARMA, INC. 2015 STOCK OPTION AND INCENTIVE PLAN (as amended) (Filed With SEC on May 4, 2021)

First Amendment to Employment Agreement dated February 5, 2021, by and between the Company and Sanjay S. Shukla, M.D., M.S (Filed With SEC on March 24, 2021)

Amendment No. 2 to Common Stock Sales Agreement, dated November 13, 2020, between the Registrant and H.C. Wainwright & Co., LLC (Filed With SEC on November 13, 2020)

Registration Rights Agreement, dated September 11, 2020, by and between aTyr Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on September 14, 2020)

aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended (Filed With SEC on May 8, 2020)

Description of Common Stock of the Registrant (Filed With SEC on March 26, 2020)

Form of Underwriting Agreement (Filed With SEC on February 3, 2020)

Common Stock Sales Agreement, dated May 21, 2019, between the Registrant and H.C. Wainwright & Co., LLC (Filed With SEC on May 22, 2019)

Employment Offer Letter by Registrant and Ms. Nancy Krueger, Esq., dated October 7, 2014 (Filed With SEC on May 14, 2019)

aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended (Filed With SEC on May 10, 2019)

Securities Purchase Agreement, dated April 10, 2019, by and among aTyr Pharma, Inc. and the investors thereunder (Filed With SEC on April 11, 2019)

aTYR PHARMA INC (21)